VA

VR Adviser Portfolio holdings

AUM $2.02B
1-Year Est. Return 169.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+169.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$732M
AUM Growth
-$47M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1
+$61.4M
2
+$34.2M
3
+$20M
4
RLMD icon
Relmada Therapeutics
RLMD
+$19.6M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$18.3M

Top Sells

1
+$43M
2
+$15.9M
3
+$14.9M
4
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$14.8M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$12.3M

Sector Composition

1 Healthcare 95.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$603K 0.08%
250,000
-3,177,461
27
– –
-3,800,000
28
– –
-706,050
29
– –
-552,882
1
2